Mei Wong

发表

IMI – Oral biopharmaceutics tools project – Evaluation of bottom‐up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes

Amitava Mitra, Jian Lin, Mai Anh Nguyen, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

IMI – Oral biopharmaceutics tools project – Evaluation of bottom‐up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results

Amitava Mitra, Jian Lin, Mai Anh Nguyen, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

IMI – oral biopharmaceutics tools project – evaluation of bottom‐up PBPK prediction success part 1: Characterisation of the OrBiTo database of compounds

Xavier Pepin, Leon Aarons, Hans Lennernäs, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Lead Identification/Optimization

M. McAllister, Mei Wong, 2017 .

Abstract B269: Pharmacodynamic and correlative biomarker analyses in clinical trials of XL184, an oral, potent inhibitor of MET, VEGFR2, and RET

J. Li, Lora Zhao, V. Vysotskaia, 2009 .

Early Drug Development: From a Drug Candidate to the Clinic

B. Henry, M. McAllister, Mei Wong, 2018, Early Drug Development.

Application of COSMO-RS as an excipient ranking tool in early formulation development.

Agnieszka Pozarska, Mei Wong, K. Pencheva, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.